Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Kazia calls for greater awareness of the most lethal women's disease in Australia
2019-05-08 09:55
Kazia Presents Positive Cantrixil Phase I Data at AACR Conference
2019-04-01 11:29
Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting
2019-03-25 13:25
Kazia Share Purchase Plan Raises A$0.8 Million, Taking Total Funds Raised to A$4.2 Million
2018-11-20 12:53
Progress Update on GDC-0084 Program
2018-10-29 18:00
Kazia Enters Clinical Collaboration to Investigate Use of Brain Cancer Drug GDC-0084 in Breast Cancer
2018-10-22 18:00
Kazia Raises A$3.4 Million to Progress R&D Programs
2018-10-18 09:21
Cantrixil Phase I Study Progresses To Next Stage
2018-10-10 15:15
Kazia Releases Preliminary Cantrixil Phase I Data
2018-06-19 18:00
Commencement Of Phase II Clinical Study Of GDC-0084
2018-03-29 08:33
Kazia Receives FDA Orphan Designation for GDC-0084
2018-02-23 17:20
1
2
3
4